Healthcare Biotech

The Latest Updates for Healthcare and Biotech

Why is US health care still the most expensive in the world after decades of cost-cutting initiatives? Feb 16, 2026 - By Patrick Aguilar, Washington University in St. Louis In announcing its “Great Healthcare Plan” in January 2026, the Trump administration became the… ...
A billion-dollar drug was found in Easter Island soil – what scientists and companies owe the Indigenous people they studied Oct 7, 2025 - By Ted Powers, University of California, Davis An antibiotic discovered on Easter Island in 1964 sparked a billion-dollar pharmaceutical success story. Yet… ...
RNA has newly identified role: Repairing serious DNA damage to maintain the genome Jun 19, 2025 - By Francesca Storici, Georgia Institute of Technology Your DNA is continually damaged by sources both inside and outside your body. One especially… ...
Top Healthcare Companies scored from recent earnings including Humana May 30, 2025 - By InvestMacro Research Earnings season continues on and our latest update highlights some of the top companies that have been recently added… ...
Massachusetts Biotech Advances Novel Cytokine Therapies Nov 16, 2023 - Source: Dr. Robert Driscoll (11/15/23) Wedbush sees over 300% upside for Werewolf stock based on early clinical success for its PREDATOR platform and… ...
Telehealth Co. Signs Largest Client Yet Mar 30, 2023 - Source: Streetwise Reports (3/30/23) Onboarding will begin in April for the health care system that has more than 1,200 care centers in seven… ...
Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered Mar 6, 2023 - By Dana Goldman, University of Southern California and Karen Van Nuys, University of Southern California Pharmaceutical giant Eli Lilly is slashing the… ...
Exploring Why The Economist Named this Biotech ‘One To watch’ in 2023 Jan 24, 2023 - Source: Streetwise Reports (1/23/23) As more researchers delve into the medicinal potentials of once-verboten compounds, forward-thinking companies like Awakn Life Sciences Corp. are… ...
Biopharma Co.’s Burn Tissue Removal Product Approved Jan 6, 2023 - Source: Swayampakula Ramakanth (1/4/23) Because of the green light from the U.S. Food and Drug Administration, H.C. Wainwright & Co. raised its target… ...
Tech. Analyst Says Pharma Co. Is at a Favorable Risk/Reward Ratio Dec 29, 2022 - Source: Clive Maund (12/28/22) Technical analyst Clive Maund reviews Algernon Pharmaceuticals Inc.'s 6-month, 3-year, and 9-year charts to tell you whether you should… ...
Biotech at Good Entry Point for Investors, Analyst Says Dec 21, 2022 - Source: Andrew Partheniou (12/20/22) The company, focused on psychedelic-assisted psychotherapies to better treat addiction, is worth more than the CA$10 million the market… ...
Why One Fund Owns 13% of This Small-Cap Pharma Dec 14, 2022 - Source: Streetwise Reports (12/12/22) Clinical-stage Algernon Pharmaceuticals' multiple pipelines include testing a psychedelic for the treatment of stroke, and testing other drugs for… ...
Biotech Co.’s Shares Soar to New 52-Week High Dec 8, 2022 - Source: Streetwise Reports (12/7/22) Prometheus Biosciences Inc. shares traded 170% higher to a new 52-week intraday high after the company reported positive results… ...
Expert Says Health Tech Co. Is in Another Buy Spot Dec 1, 2022 - Source: Clive Maund (11/30/22) Expert Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you why he believes it is… ...
Biopharma Co. Trades to New 52-Week High Nov 29, 2022 - Source: Streetwise Reports (11/28/22) Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successfully met… ...
US Biopharma Co. Is Attractive, Derisked Investment, Analyst Says Nov 14, 2022 - Source: Streetwise Reports (11/11/22) With late-stage drug candidates and major near-term catalysts, undervalued Aldeyra Therapeutics warrants a Buy to Outperform rating and consideration… ...
Expert Says Buy Pharma Co. Stock ‘as Soon as Possible’ Oct 28, 2022 - Source: Clive Maund (10/25/22) Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's attention. In light… ...
Biopharma Co.’s Shares Roll to New 52-Week High Price Oct 14, 2022 - Source: Streetwise Reports (10/12/22) Shares of DICE Therapeutics Inc. traded 62% higher yesterday and established a new 52-week intraday high after the company… ...
Biopharma Co. Partners With Merck for Combo Drug Trial Oct 13, 2022 - Source: Dr. Joseph Pantginis (10/12/22) With this and other clinical studies, the U.S. company has a busy and, thus, catalyst-rich Q4/22 ahead, noted… ...
Trial Results Show New Drug Improves Dry Eye Symptoms Jul 20, 2022 - These study data from Aldeyra Therapeutics Inc. solidified the therapeutic's path to filing a new drug application, potentially in Q3/22, noted an… ...
Biopharma Co. Looks to Expand New Drug Label Down the Road Jul 20, 2022 - ScPharmaceuticals Inc. just released topline results from a Phase 2 pilot study supporting the drug developer that is pursuing the expansion of… ...
Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity Jul 20, 2022 - Source: Streetwise Reports 07/18/2022 One junior biotech company that attempts to treat current health problems with older previously approved drugs, recently completed… ...
Why are drug names so long and complicated? A pharmacist explains the logic behind the nomenclature Jul 19, 2022 - By Jasmine Cutler, University of South Florida At some point in your life, you’ll likely find yourself with a prescription from your… ...
Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’ Jul 18, 2022 - Source: Patrick Trucchio 07/15/2022 Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD)… ...
Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry Jul 18, 2022 - Source: Jason McCarthy 07/14/2022 One healthcare co. is currently rated a Buy and is making a push for a share of the… ...
Pharma Co. Reduces Mortality Rates by 70% in ALS Trial Jul 18, 2022 - Source: Streetwise Reports 07/15/2022 Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to… ...
Biopharma Co. Posts 17% BMI Reduction in Ph. 2 Trial Jul 18, 2022 - Source: Streetwise Reports 07/14/2022 Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its… ...
Analyst Sees ‘Attractive Long-Term Economics’ for Healthcare Co. Jul 15, 2022 - Source: Andrew Partheniou 07/13/2022 One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with… ...
Results of Dermatitis Clinical Trial Due This Summer Jun 23, 2022 - Enrollment is now done for VYNE Therapeutics Inc.'s Phase 2a trial following encouraging Phase 1b efficacy data, noted an H.C. Wainwright &… ...
New Positive Data Seem to Support Drug Label Expansion Jun 23, 2022 - Checkpoint Therapeutics Inc., the biopharma behind this late-stage monoclonal antibody for metastatic cutaneous squamous cell carcinoma, could use the new trial results… ...

Full Archive Here